Swindells S, Andrade-Villanueva JF, Richmond GJ, et al. Long-acting cabotegravir + rilpivirine as maintenance therapy: ATLAS week 48 results. CROI 2019, abstract 139.
Stoppen met nucleos(t)ide-analogen bij HBeAg-negatieve chronische hepatitis B?
aug 2023 | Hepatitis, Hepatologie